Course offering number:0904-701
Course ID:
2233
GO BACK TO BROWSE ONLINE TRAINING COURSES PAGE
FDA Quarterly Briefing–April 2009
In Conjunction with Wiley-Blackwell
Pre-recorded Course
AN ON-DEMAND ONLINE TRAINING FORMAT
Dr. Sandy Weinberg, Associate Professor of Health Care Management (Regulation) at Clayton State University, part of the Georgia State University System; retired regulatory professional from the drug, device and vaccine industries.
Dr. Sandy Weinberg, is currently a professor of Health Care Management in the School for Professional Studies at Clayton State University,
part of the Georgia State University System. He is teaching and researching Regulation and Biodefense. Dr. Weinberg is a consultant to the
FDA regulated industries and is a former consultant to the FDA and other international regulatory agencies including Health Canada, NIH, CDC,
EMEA, and the Swiss Ministry of Health.”
He has been a leader in the field of system validation for more than twenty years, and a practitioner in regulatory submissions, auditing,
international liaison, and biodefense vaccine development. Dr. Weinberg is the author of numerous books and articles, including The GALP
Regulatory Handbook, The Handbook of System Validation, Good Laboratory Practice Regulations, and The Handbook of Drug Regulatory
Submissions. His most recent articles include “Cost Effective Validation for LIMS” and “Conforming to Part 11 Regulations”.
Dr. Weinberg is a member of the Board of the KEMA Registered Quality (ISO 9000 Certifier) in the United States and the Netherlands.
Recently retired, Dr. Weinberg was Senior Director for Biodefense at GE Healthcare and Vice President of Tikvah Therapeutics; as well as an
investor in and Board member of several international biomedical companies.
Working as a consultant, Dr. Weinberg provides auditing and advisory services in regulatory areas. Recent projects include the auditing and
certification of a chromatography control system; a business development and fund raising project for a biodefense vaccine company; an
Orphan Drug submission; and the validation of a Laboratory Information Management System. Much of Dr. Weinberg’s practice is centered in
the US, Western Europe and Israel.
|